Helen Joseph Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2015
NCT02333799
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

CHRU Themba Lethu Clinic - Helen Joseph Hospital

Active Ingredients

Drugs in Phase 3 Trials (3)

bedaquiline (sirturo) (1 trial)

linezolid (zyvox) (1 trial)

pretomanid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3